FdaApplication
BLA 761451
Identifiers
- fda_app_no: BLA761451
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2026-04-24 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAPHNELO | ANIFROLUMAB-FNIA | 120MG/0.8ML | VIAL;SINGLE-USE |
| SAPHNELO | ANIFROLUMAB-FNIA | 120MG/0.8ML | Injection |
2 products